Piperazines as anti-obesity agents

Details for Australian Patent Application No. 2008333173 (hide)

Owner AstraZeneca AB (PUBL)

Inventors Higginbottom, Michael; Boyd, Joseph W.; Brown, Giles A.

Agent Davies Collison Cave

Pub. Number AU-A-2008333173

PCT Pub. Number WO2009/071658

Priority 61/022,983 23.01.08 US; 0702696-6 05.12.07 SE

Filing date 5 December 2008

Wipo publication date 11 June 2009

International Classifications

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071658 Priority application(s): WO2009/071658

12 August 2010 Alteration of Name

  The name of the applicant has been altered to AstraZeneca AB

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333180-Apparatus and method for detecting DNA damage

2008333168-Binder composition and asphalt mixture